ZURA BIO LTD
ZURA · NASDAQ
Updated at 2026-10-15 10:28:15
- Today's High
- $4.61
- Today’s Low
- $4.17
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.23
- Previous Close
- $4.41
- Volume
- 5.74M
- Market Cap
- $526.29M
- P/E Ratio
- --
- EPS
- $-0.78
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1489 W. WARM SPRINGS ROAD, HENDERSON, NV, UNITED STATES, 89014
- Country
- US
- Listing Date
- 2021-07-16
- Fiscal Year End
- December
- Shares Outstanding
- 95M
- CIK
- 0001855644
- Website
- zurabio.com
Zura Bio Limited (Ticker: ZURA) is a biotechnology firm dedicated to developing breakthrough therapies for autoimmune disorders and rare diseases. The company features a diverse pipeline of drug candidates, underpinned by rigorous research methodologies and clinical trials that validate their efficacy and safety profiles. With a leadership team experienced in biopharmaceuticals and strong strategic partnerships, Zura Bio is well-positioned to capitalize on growth opportunities in the sector, making it an attractive investment prospect for institutional investors seeking exposure to innovative therapeutic solutions.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$29.32M
2026-03-31
$25.49M
2025-12-31
$18.41M
2025-09-30
$19.51M
Net Income
2026-06-30
-$26.3M
2026-03-31
-$24.22M
2025-12-31
-$17.17M
2025-09-30
-$18.04M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.21
2026-03-31
$-0.22
2025-12-31
$-0.49
2025-09-30
$-0.21
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$26.36M
2026-03-31
-$24.2M
2025-12-31
-$17.16M
2025-09-30
-$18.02M
Effective Tax Rate
2026-06-30
0.3%
2026-03-31
--
2025-12-31
-167.13%
2025-09-30
-11.06%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $29.32M | $25.49M | $18.41M | $19.51M |
| Net Income | -$26.3M | -$24.22M | -$17.17M | -$18.04M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.21 | $-0.22 | $-0.49 | $-0.21 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$26.36M | -$24.2M | -$17.16M | -$18.02M |
| Effective Tax Rate | 0.3% | -- | -167.13% | -11.06% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.